Cereno Scientific AB

2 trials Commercial sponsor

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

1 Completed trials

1 Countries active

0 Unique IMPs

100% Results reported

Phase I

Phase I (Other)

Phase I: 1 Phase I (Other): 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Idiopathic pulmonary fibrosis 1

All trials

2 total

A Phase 1, open label, randomised, 2-period, 2 sequence, 7-days repeat-dosing, crossover oral pharmacokinetic trial comparing multiple dosin… Pending

2025-524883-39-00 Phase I (Other) 1 country
A trial in healthy volunteers to study safety, tolerability, CS014-levels and effects in the body, after single and repeated doses of CS014,… Ended

2024-510878-24-00 Phase I 1 country

Showing 1–2 of 2 trials

← All sponsors A–Z